Meth Thomas's most recent trade in Enviva Inc was a trade of 10,135 Common Stock done . Disclosure was reported to the exchange on Jan. 29, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Enviva Inc | Meth Thomas | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 10,135 | 483,303 (1%) | 0% | 0 | Common Stock | |
Enviva Inc | Thomas Meth | Director, President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 10,135 | 0 | - | - | Restricted Stock Units | |
Enviva Inc | Meth Thomas | Director, President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.58 per share. | 29 Jan 2024 | 3,737 | 479,566 (1%) | 0% | 0.6 | 2,167 | Common Stock |
Enviva Inc | Thomas Meth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2023 | 13,259 | 0 | - | - | Series A Preferred Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.71 per share. | 15 Jun 2023 | 13,259 | 473,168 (1%) | 0% | 37.7 | 499,997 | Common Stock |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 11,181 | 465,495 (1%) | 0% | 0 | Common Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.27 per share. | 06 Mar 2023 | 5,586 | 459,909 (1%) | 0% | 39.3 | 219,362 | Common Stock |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 13,259 | 13,259 | - | - | Series A Preferred Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 2,142 | 454,314 (1%) | 0% | - | Common Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 24,736 | 24,736 | - | - | Restricted Stock Units | |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2023 | 18,851 | 459,818 (1%) | 0% | 0 | Common Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.83 per share. | 31 Jan 2023 | 7,646 | 452,172 (1%) | 0% | 44.8 | 342,770 | Common Stock |
Enviva Inc | Thomas Meth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 10,135 | 444,590 (1%) | 0% | 0 | Common Stock | |
Enviva Inc | Thomas Meth | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 10,135 | 0 | - | - | Restricted Stock Units | |
Enviva Inc | Thomas Meth | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 46.04 per share. | 29 Jan 2023 | 3,623 | 440,967 (1%) | 0% | 46.0 | 166,803 | Common Stock |
Enviva Inc | Thomas Meth | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2022 | 1,784 | 434,455 (1%) | 0% | - | Common Stock | |
Enviva Inc | Thomas Meth | President | Purchase of securities on an exchange or from another person at price $ 50.84 per share. | 12 Oct 2022 | 5,000 | 432,671 (1%) | 0% | 50.8 | 254,200 | Common Stock |
Enviva Inc | Thomas Meth | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2022 | 1,416 | 427,671 (1%) | 0% | - | Common Stock | |
Enviva Inc | Thomas Meth | President | Purchase of securities on an exchange or from another person at price $ 58.78 per share. | 23 Jun 2022 | 8,600 | 426,255 (1%) | 0% | 58.8 | 505,508 | Common Stock |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 1,192 | 417,655 (1%) | 0% | - | Common stock | |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 25 Feb 2022 | 1,256 | 416,463 (1%) | 0% | - | Common stock | |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 23,127 | 426,375 (1%) | 0% | 0 | Common Stock | |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.07 per share. | 01 Feb 2022 | 11,168 | 415,207 (1%) | 0% | 72.1 | 804,878 | Common Stock |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 8,672 | 8,672 | - | - | Restricted Stock Units | |
Enviva Inc | Thomas Meth | EVP & Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.18 per share. | 30 Jan 2022 | 6,421 | 403,248 (1%) | 0% | 65.2 | 418,521 | Common Stock |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 26 Nov 2021 | 1,306 | 409,669 (1%) | 0% | - | Common units | |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Oct 2021 | 332,791 | 408,363 (1%) | 0% | - | Common units | |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.10 per share. | 04 Jun 2021 | 7,967 | 75,572 (0%) | 0% | 48.1 | 383,213 | Common units |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.82 per share. | 31 Jan 2021 | 4,939 | 83,539 | - | 49.8 | 246,061 | Common units |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 17,906 | 94,547 (0%) | 0% | 0 | Common units representing limited partner interests | |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 8,792 | 8,792 | - | - | Phantom units | |
Enviva Inc | Thomas Meth | Exec VP Sales & Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 48.34 per share. | 27 Jan 2021 | 6,069 | 88,478 (0%) | 0% | 48.3 | 293,375 | Common units representing limited partner interests |